These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23702081)

  • 1. Do patents impede the provision of genetic tests in Australia?
    Nicol D; Liddicoat J
    Aust Health Rev; 2013 Jun; 37(3):281-5. PubMed ID: 23702081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing innovation and access to healthcare through the patent system--an Australian perspective.
    Nicol D
    Community Genet; 2005; 8(4):228-34. PubMed ID: 16244477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent law--balancing profit maximization and public access to technology.
    Beckerman-Rodau A
    Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continuing saga of patents and non-invasive prenatal testing.
    Hawkins N; Nicol D; Chandrasekharan S; Cook-Deegan R
    Prenat Diagn; 2019 May; 39(6):441-447. PubMed ID: 30900262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human gene patents: the possible impacts on genetic services healthcare.
    Walpole IR; Dawkins HJ; Sinden PD; O'Leary PC
    Med J Aust; 2003 Aug; 179(4):203. PubMed ID: 12914511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.
    Cook-Deegan R; DeRienzo C; Carbone J; Chandrasekharan S; Heaney C; Conover C
    Genet Med; 2010 Apr; 12(4 Suppl):S15-38. PubMed ID: 20393305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there still a place for gene patents in Australia? Implications of recent United States and European case law.
    Ridley A; Nicol D
    J Law Med; 2011 Dec; 19(2):282-99. PubMed ID: 22320004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct to confusion: lessons learned from marketing BRCA testing.
    Matloff E; Caplan A
    Am J Bioeth; 2008 Jun; 8(6):5-8. PubMed ID: 18726769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research-tool patents: issues for health in the developing world.
    Barton JH
    Bull World Health Organ; 2002; 80(2):121-5. PubMed ID: 11953790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of patents and licenses on the provision of clinical genetic testing services.
    Cho MK; Illangasekare S; Weaver MA; Leonard DG; Merz JF
    J Mol Diagn; 2003 Feb; 5(1):3-8. PubMed ID: 12552073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patents and the supply of therapeutic products.
    Hayhurst WL
    Law Med Health Care; 1992; 20(3):235-7. PubMed ID: 1434767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human genome, property of all: opportunities under the ALRC inquiry into gene patenting and human health.
    Hinojosa JP
    Syd Law Rev; 2004 Sep; 26(3):447-55. PubMed ID: 16523584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gene patent controversy on Twitter: a case study of Twitter users' responses to the CHEO lawsuit against Long QT gene patents.
    Du L; Kamenova K; Caulfield T
    BMC Med Ethics; 2015 Aug; 16():55. PubMed ID: 26302779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patents to "treat me", no patents to "test me": an analysis of the 2009 Senate inquiry into gene patents.
    Triffett D
    J Law Med; 2010 May; 17(5):800-6. PubMed ID: 20552942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fortune and hindsight: gene patents' muted effect on medical practice.
    Sherkow JS; Abbott R
    Br Med Bull; 2018 Jun; 126(1):37-45. PubMed ID: 29608656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.